Peteris Tretjakovs currently works as a Professor and Head
of the Department of Human Physiology and Biochemistry, Faculty of Medicine,
Riga Stradins University. He received a Master’s degree in Biology from the
Faculty of Biology, University of Latvia, in 1982, and a Ph.D. in Biology from
the Latvian Institute of Experimental and Clinical Medicine in 1995. He is a
member of the Latvian Society of Laboratory Specialists. His research interests
include the study of clinically useful biomarkers in the prevention and
management of obesity-related diseases, focusing on new and early risk factors
of type-2 diabetes mellitus and coronary artery disease and, for these purposes,
developing non-invasive techniques (e.g., laser Doppler flowmetry and imaging,
intravital videocapillaroscopy, transcutaneous gas monitoring) for the evaluation of
vasomotor/neurovascular dysfunction and methods (e.g., xMAP) for testing the
expression of risk cytokines, growth factors and gene polymorphism, insulin
resistance, etc. He won the “Distinguished Research Award” (2005), which was
awarded by the Kuwait Foundation for Advancement of Sciences.
Peteris Tretjakovs currently works as a Professor and Head
of the Department of Human Physiology and Biochemistry, Faculty of Medicine,
Riga Stradins University. He received a Master’s degree in Biology from the
Faculty of Biology, University of Latvia, in 1982, and a Ph.D. in Biology from
the Latvian Institute of Experimental and Clinical Medicine in 1995. He is a
member of the Latvian Society of Laboratory Specialists. His research interests
include the study of clinically useful biomarkers in the prevention and
management of obesity-related diseases, focusing on new and early risk factors
of type-2 diabetes mellitus and coronary artery disease and, for these purposes,
developing non-invasive techniques (e.g., laser Doppler flowmetry and imaging,
intravital videocapillaroscopy, transcutaneous gas monitoring) for the evaluation of
vasomotor/neurovascular dysfunction and methods (e.g., xMAP) for testing the
expression of risk cytokines, growth factors and gene polymorphism, insulin
resistance, etc. He won the “Distinguished Research Award” (2005), which was
awarded by the Kuwait Foundation for Advancement of Sciences.